Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by CEVEC Pharmaceuticals GmbH

CEVEC's License Partner RZNOMICS Inc. Receives Approval to Initiate Clinical Development of CAP(R) Ad Technology-Produced Gene Therapy Vector in Liver Cancer Patients
From CEVEC Pharmaceuticals GmbH
Via AccessWire
CEVEC and UCB Sign Agreement for the use of CEVEC's ELEVECTA(R) AAV Manufacturing Technology in Gene Therapy
From CEVEC Pharmaceuticals GmbH
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
CEVEC Pharmaceuticals GmbH: CEVEC Closes Growth Financing Round to Serve Strong Demand in Viral Vector Technologies for Cell and Gene Therapies
From CEVEC Pharmaceuticals GmbH
Via AccessWire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.